Stay updated with breaking news from Nasdaq Reta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the stock. RETA has been the topic of a number of other research reports. Jefferies Financial Group downgraded Reata Pharmaceuticals from a buy rating to a hold rating […]
Altium Capital Management LP bought a new stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 35,000 shares of the company’s stock, valued at approximately $3,182,000. Reata Pharmaceuticals makes up 1.8% of Altium Capital […]
StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Friday morning. The brokerage issued a sell rating on the stock. Other research analysts also recently issued research reports about the stock. Stifel Nicolaus downgraded shares of Reata Pharmaceuticals from a buy rating to a hold rating […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares traded. The stock had previously closed at $170.32. Analysts Set New Price Targets A number of research firms have weighed in […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares. The stock had previously closed at $170.32. Analysts Set New Price Targets Several brokerages have issued reports […]